Takeda Pharma Files 6-K Report
Ticker: TKPHF · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Takeda filed a 6-K on 6/12/25, confirming its Tokyo HQ and SEC filings.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on June 12, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan. Takeda is registered under the 1934 Act with SEC file number 001-38757.
Why It Matters
This filing is a routine report for foreign private issuers, providing updated information to the SEC and investors about the company's status and location.
Risk Assessment
Risk Level: low — This is a standard regulatory filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Filer
- 001-38757 (company) — SEC File Number
- 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan (company) — Principal Executive Offices
- June 12, 2025 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is Takeda Pharmaceutical Company Limited's SEC file number?
Takeda Pharmaceutical Company Limited's SEC file number is 001-38757.
Where are Takeda's principal executive offices located?
Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is June 12, 2025.
Does Takeda file its annual reports under Form 20-F or Form 40-F?
Takeda indicates it files its annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).